These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29328425)

  • 1. Bioinformatics analysis of the CDK2 functions in neuroblastoma.
    Bo L; Wei B; Wang Z; Kong D; Gao Z; Miao Z
    Mol Med Rep; 2018 Mar; 17(3):3951-3959. PubMed ID: 29328425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray expression analysis of MYCN-amplified neuroblastoma cells after inhibition of CDK2.
    Song H; Wu F; Li S; Wang Z; Liu X; Cui Y; Lin C
    Neoplasma; 2017; 64(3):351-357. PubMed ID: 28253714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feature genes in metastatic breast cancer identified by MetaDE and SVM classifier methods.
    Tuo Y; An N; Zhang M
    Mol Med Rep; 2018 Mar; 17(3):4281-4290. PubMed ID: 29328377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis to screen key genes implicated in the differentiation of induced pluripotent stem cells to hepatocytes.
    Lin R; Wang Y; Ji K; Liu Z; Xiao S; Zhou D; Chen Q; Shi B
    Mol Med Rep; 2018 Mar; 17(3):4351-4359. PubMed ID: 29328449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key candidate genes involved in melanoma metastasis.
    Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
    Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis.
    Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D
    Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
    He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
    Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.
    Giono LE; Manfredi JJ
    Mol Cell Biol; 2007 Jun; 27(11):4166-78. PubMed ID: 17371838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
    Wang J; Tian Y; Chen H; Li H; Zheng S
    Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis.
    Kuang Z; Guo L; Li X
    Mol Med Rep; 2017 Oct; 16(4):4685-4693. PubMed ID: 28791394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis.
    Ye Q; Lei L; Aili AX
    Eur J Gynaecol Oncol; 2015; 36(3):283-9. PubMed ID: 26189254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis.
    Zhang K; Kong X; Feng G; Xiang W; Chen L; Yang F; Cao C; Ding Y; Chen H; Chu M; Wang P; Zhang B
    J Ovarian Res; 2018 Feb; 11(1):16. PubMed ID: 29482638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
    Kang J; Sergio CM; Sutherland RL; Musgrove EA
    BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer.
    Zhen YB; Guo XL; Xu B; Zhao HW; Xu CJ
    Neoplasma; 2016; 63(6):856-864. PubMed ID: 27565323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.